James B. Geake

Utility of EBUS-TBNA for diagnosis of mediastinal tuberculous lymphadenitis: a multicentre Australian experience.

Daniel P Steinfort, L. Irving, M. Farmer, 2015, Journal of thoracic disease.

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

E. Dabscheck, C. Cates, R. Wood-Baker, 2015, The Cochrane database of systematic reviews.

Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis

S. Bell, S. Yerkovich, J. Geake, 2015, Internal medicine journal.

Pregnancy and cystic fibrosis: Approach to contemporary management

S. Bell, L. Callaway, J. Geake, 2014, Obstetric medicine.

Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations

J. Geake, Ching Kuo Tan, Gui Quan Say, 2016, Therapeutics and clinical risk management.